The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Bravura Solutions Ltd
F:BRA
|
AU |
|
Mitra Adiperkasa Tbk PT
IDX:MAPI
|
ID |
|
Doxa AB
F:1DO
|
SE |
|
El En SpA
MIL:ELN
|
IT |
|
Initio Inc
OTC:INTO
|
US |
|
D
|
Defense Metals Corp
OTC:DFMTF
|
CA |
|
NiCAN Ltd
F:W8Y
|
CA |
|
B
|
Ball Corp
NYSE:BALL
|
US |
|
F
|
Fluor Corp
DUS:FLU
|
US |
|
Flex Ltd
NASDAQ:FLEX
|
US |
|
U
|
United Therapeutics Corp
XMUN:UTH
|
US |
|
Orient Overseas (International) Ltd
F:ORI
|
HK |
|
Eledon Pharmaceuticals Inc
F:2TK
|
US |
|
V
|
Vilkyskiu Pienine AB
XMUN:UDW
|
LT |
|
Invitation Homes Inc
F:4IV
|
US |
|
Z
|
ZIM Integrated Shipping Services Ltd
F:2SV
|
IL |
|
H
|
Huadian Power International Corp Ltd
OTC:HPIFY
|
CN |
|
D
|
DigitalOcean Holdings Inc
NYSE:DOCN
|
US |
|
Fanuc Corp
F:FUCA
|
JP |
|
D
|
DigitalOcean Holdings Inc
XMUN:0SU
|
US |
|
United Therapeutics Corp
NASDAQ:UTHR
|
US |
|
V
|
Valneva SE
XMUN:AYJ
|
FR |
|
Libas Consumer Products Ltd
NSE:LIBAS
|
IN |
|
V
|
Ventas Inc
SWB:VEN
|
US |
Bravura Solutions Ltd (BRA)’s 12-month stock price forecast through October 2027 has a consensus target of €1.65, implying 20% downside. The forecast is based on price targets from 8 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
BRA is 1.65 EUR with a low forecast of 1.51 EUR and a high forecast of 2.03 EUR.
Over the last 11 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 4 years is 4%.
Over the last 11 years, the compound annual growth rate for Operating Income has been 32%. The projected CAGR for the next 4 years is 4%.
The compound annual growth rate for Pre-Tax Income over the next 3 years is 8%.
The compound annual growth rate for Net Income over the next 4 years is -13%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more